Babcock & Wilcox (BWSN) CFO Reports 20,000-Share Purchase at $1.55
Rhea-AI Filing Summary
Cameron M. Frymyer, Chief Financial Officer of Babcock & Wilcox Enterprises, Inc. (BWSN), reported an insider purchase of common stock. The Form 4 shows a purchase on 08/19/2025 of 20,000 shares at a price of $1.55 per share, increasing his beneficial ownership to 153,805 shares. The filing was signed by an attorney-in-fact on 08/20/2025. No derivative transactions were reported and no other material details are provided.
Positive
- CFO purchased shares, signaling insider buying at $1.55 per share
- Beneficial ownership increased to 153,805 shares after the transaction
- Form 4 disclosure appears complete with transaction date and signature
Negative
- None.
Insights
TL;DR: CFO purchased 20,000 BWSN shares at $1.55, modestly increasing insider stake to 153,805 shares.
The transaction is a straightforward open-market purchase by the company's CFO, reported on Form 4. At 20,000 shares and $1.55 per share, the trade size appears modest relative to typical institutional thresholds; it does, however, indicate management-level buying interest. The filing contains no derivatives, no plan designation (10b5-1), and no additional context such as large block trades or related-party involvement. Impact on valuation is limited given the small size, so this is a routine insider purchase from a disclosure perspective.
TL;DR: Insider disclosure is complete for the reported transaction and shows a direct beneficial increase.
The Form 4 properly discloses the reporting person, relationship (CFO), transaction date, price, and resulting beneficial ownership. The signature is provided by an attorney-in-fact, dated 08/20/2025, which satisfies execution formalities. There are no indications of planned trading arrangements or derivative activity in this filing. Governance-wise, the disclosure aligns with Section 16 requirements and raises no procedural concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,000 | $1.55 | $31K |
AI-generated analysis. How Rhea-AI works. Not financial advice.